These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17488822)

  • 1. Subtype-selective sodium channel blockers promise a new era of pain research.
    Priest BT; Kaczorowski GJ
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8205-6. PubMed ID: 17488822
    [No Abstract]   [Full Text] [Related]  

  • 2. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.
    Jarvis MF; Honore P; Shieh CC; Chapman M; Joshi S; Zhang XF; Kort M; Carroll W; Marron B; Atkinson R; Thomas J; Liu D; Krambis M; Liu Y; McGaraughty S; Chu K; Roeloffs R; Zhong C; Mikusa JP; Hernandez G; Gauvin D; Wade C; Zhu C; Pai M; Scanio M; Shi L; Drizin I; Gregg R; Matulenko M; Hakeem A; Gross M; Johnson M; Marsh K; Wagoner PK; Sullivan JP; Faltynek CR; Krafte DS
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8520-5. PubMed ID: 17483457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future potential and status of selective sodium channel blockers for the treatment of pain.
    Priest BT
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):682-92. PubMed ID: 19736626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imidazopyridines: a novel class of hNav1.7 channel blockers.
    London C; Hoyt SB; Parsons WH; Williams BS; Warren VA; Tschirret-Guth R; Smith MM; Priest BT; McGowan E; Martin WJ; Lyons KA; Li X; Karanam BV; Jochnowitz N; Garcia ML; Felix JP; Dean B; Abbadie C; Kaczorowski GJ; Duffy JL
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1696-701. PubMed ID: 18243692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.
    Kort ME; Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Johnson MS; Pacofsky GJ; Thomas JB; Carroll WA; Krambis MJ; Liu D; Shieh CC; Zhang X; Hernandez G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Marsh KC; Murray BP; Liu J; Werness S; Faltynek CR; Krafte DS; Jarvis MF; Chapman ML; Marron BE
    J Med Chem; 2008 Feb; 51(3):407-16. PubMed ID: 18176998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7.
    Williams BS; Felix JP; Priest BT; Brochu RM; Dai K; Hoyt SB; London C; Tang YS; Duffy JL; Parsons WH; Kaczorowski GJ; Garcia ML
    Biochemistry; 2007 Dec; 46(50):14693-703. PubMed ID: 18027973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain.
    Bregman H; Berry L; Buchanan JL; Chen A; Du B; Feric E; Hierl M; Huang L; Immke D; Janosky B; Johnson D; Li X; Ligutti J; Liu D; Malmberg A; Matson D; McDermott J; Miu P; Nguyen HN; Patel VF; Waldon D; Wilenkin B; Zheng XM; Zou A; McDonough SI; DiMauro EF
    J Med Chem; 2011 Jul; 54(13):4427-45. PubMed ID: 21634377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted biaryl pyrazoles as sodium channel blockers.
    Tyagarajan S; Chakravarty PK; Zhou B; Taylor B; Fisher MH; Wyvratt MJ; Lyons K; Klatt T; Li X; Kumar S; Williams B; Felix J; Priest BT; Brochu RM; Warren V; Smith M; Garcia M; Kaczorowski GJ; Martin WJ; Abbadie C; McGowan E; Jochnowitz N; Parsons WH
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5480-3. PubMed ID: 20709545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain.
    Gaida W; Klinder K; Arndt K; Weiser T
    Neuropharmacology; 2005 Dec; 49(8):1220-7. PubMed ID: 16182323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Block of Nav1.8 by small molecules.
    Krafte DS; Chapman M; Marron B; Atkinson R; Liu Y; Ye F; Curran M; Kort M; Jarvis MF
    Channels (Austin); 2007; 1(3):152-3. PubMed ID: 18690030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoform-selective voltage-gated Na(+) channel modulators as next-generation analgesics.
    England S; Rawson D
    Future Med Chem; 2010 May; 2(5):775-90. PubMed ID: 21426202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibuprofen blocks changes in Na v 1.7 and 1.8 sodium channels associated with complete Freund's adjuvant-induced inflammation in rat.
    Gould HJ; England JD; Soignier RD; Nolan P; Minor LD; Liu ZP; Levinson SR; Paul D
    J Pain; 2004 Jun; 5(5):270-80. PubMed ID: 15219259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenoxyphenyl pyridines as novel state-dependent, high-potency sodium channel inhibitors.
    Shao B; Victory S; Ilyin VI; Goehring RR; Sun Q; Hogenkamp D; Hodges DD; Islam K; Sha D; Zhang C; Nguyen P; Robledo S; Sakellaropoulos G; Carter RB
    J Med Chem; 2004 Aug; 47(17):4277-85. PubMed ID: 15293999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
    Mulcahy JV; Pajouhesh H; Beckley JT; Delwig A; Du Bois J; Hunter JC
    J Med Chem; 2019 Oct; 62(19):8695-8710. PubMed ID: 31012583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of Novel α-Aminoamides Containing Benzoheterocyclic Moiety for the Treatment of Pain.
    Tong K; Zhang R; Ren F; Zhang T; He J; Cheng J; Yu Z; Ren F; Zhang Y; Shi W
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33808667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief.
    Emery EC; Luiz AP; Wood JN
    Expert Opin Ther Targets; 2016 Aug; 20(8):975-83. PubMed ID: 26941184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional up-regulation of Nav1.8 sodium channel on dorsal root ganglia neurons contributes to the induction of scorpion sting pain.
    Ye P; Hua L; Jiao Y; Li Z; Qin S; Fu J; Jiang F; Liu T; Ji Y
    Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):132-44. PubMed ID: 26764239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic pain.
    Shao PP; Ye F; Weber AE; Li X; Lyons KA; Parsons WH; Garcia ML; Priest BT; Smith MM; Felix JP; Williams BS; Kaczorowski GJ; McGowan E; Abbadie C; Martin WJ; McMasters DR; Gao YD
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5334-8. PubMed ID: 19683443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous expression and functional analysis of rat Nav1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7-23.
    John VH; Main MJ; Powell AJ; Gladwell ZM; Hick C; Sidhu HS; Clare JJ; Tate S; Trezise DJ
    Neuropharmacology; 2004 Mar; 46(3):425-38. PubMed ID: 14975698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of diphenyl amine based sodium channel blockers, effective against hNav1.2.
    Hudgens DP; Taylor C; Batts TW; Patel MK; Brown ML
    Bioorg Med Chem; 2006 Dec; 14(24):8366-78. PubMed ID: 17035036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.